发明名称 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
摘要 A first substance (such as the peptide aldehydes LLnL and LVP) inhibits the function of intracellular proteasome. A second substance (such as ranpirnase) inhibits intracellular protein synthesis or increases intracellular expression of a cyclin-dependent kinase (CDK) inhibitor. Both substances are administered in such a manner that the effects thereof are coincident. The cell cycle of affected tumor cells is therefore arrested and the cells die of apoptosis.
申请公布号 US6290951(B1) 申请公布日期 2001.09.18
申请号 US19980127619 申请日期 1998.08.01
申请人 ALFACELL CORPORATION 发明人 MIKULSKI STANISLAW M.
分类号 C12N5/06;A61K38/00;A61K38/46;A61K45/06;A61P35/00;(IPC1-7):C12N5/00 主分类号 C12N5/06
代理机构 代理人
主权项
地址